
FDA approves first oral treatment for moderately to severely active Crohn’s disease fda.gov/drugs/news-eve…
English
David T. Rubin, MD
6.4K posts

@IBDMD
Professor and Chief of GI, The University of Chicago Medicine. I specialize in and advocate for the care of IBD patients. My tweets are my own. (he/him)























Helping bring IUS to all IBD patients means navigating credentialing, billing and documentation for GIs. We cover this and more for USA IBD centers @AmJGastro. Thanks to @IBDMD @KrugCleveland and #MarlaDubinsky for making this critical work happen. journals.lww.com/ajg/Citation/9…






